The Cost of Mental Health in Ukraine
No hay miniatura disponible
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
World Bank, Washington, DC
Resumen
Descripción
This report attempts to provide a
comprehensive summary of the relevant indicators of mental
health and present a detailed analysis of the cost of
psychiatric care, particularly highlighting the cost of
mental health medications and dietary supplements in
Ukraine. The study strives to shed light on the
pharmaceutical aspect of providing care to people with
mental health conditions in Ukraine. This report consciously
presents data and analysis from the pre-COVID times in
Ukraine as the COVID-19 pandemic significantly disrupted
access to health care and medicines. Key results reveal that
out-of-pocket costs of medicines used to treat mental
disorders may exceed government spending on the entire
psychiatric care network. The report provides a detailed
review of the utilization and spending of (a) medicines
mainly used in the treatment of people with mental disorders
(neuroleptics, tranquilizers, antidepressants, and so on)
and (b) medicines that can provisionally be used in the
treatment of people with mental disorders (nootropics,
hypnotics, antiepileptic medicines, and so on).
Palabras clave
MENTAL HEALTH, MENTAL DISORDERS, SCHIZOPHRENIA, MOOD (AFFECTIVE) DISORDERS, NEUROTIC DISORDERS, FINANCING AND COST, PSYCHOTROPIC, ANTIPSYCHOTIC N05A, ANTIANXIETY N05B, ANTIDEPRESSANTS N06A, DEMENTIA N06D, ALCOHOL ADDICTION N07BB, OPIOID ADDICTION N07BC, NICOTINE ADDICTION N07BA, PROCURED MEDICINES, DIETARY SUPPLEMENTS